Case Reports Internal medicine (Tokyo, Japan). 2018 Oct 1;57(19):2843-2845. doi: 10.2169/internalmedicine.0621-17 Q21.12025
Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
奥比塔丝伟/派瑞普雷韦尔/里托那韦联合利巴韦林治疗基因1b型丙型肝炎病毒感染干扰素经治复发患者一名 翻译改进
Toru Ishikawa 1, Michitaka Imai 1, Takashi Owaki 1, Hiroki Sato 1, Yujiro Nozawa 1, Tomoe Sano 1, Akito Iwanaga 1, Keiichi Seki 1, Terasu Honma 1, Toshiaki Yoshida 1
作者单位 +展开
作者单位
DOI: 10.2169/internalmedicine.0621-17 PMID: 29780129
摘要 Ai翻译
相关内容
-
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
索磷布韦联合利巴韦林治疗丙型肝炎2基因型的疗效和安全性：日本红十字会肝病研究组的一项全国多中心研究
Takehiro Akahane et al.
Hepatology research : the official journal of the Japan Society of Hepatology. 2019 Mar;49(3):264-270.
-
Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C
索夫布韦联合利巴韦林治疗丙型肝炎的有利之处优于博赛普韦派流干扰素α及利巴韦林疗法
Shivakumar Narayanan et al.
Hepatology international. 2014 Oct;8(4):560-6.
-
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
用于治疗丙型肝炎的核苷酸聚合酶抑制剂索非布韦联合利巴韦林疗法
Edward J Gane et al.
The New England journal of medicine. 2013 Jan 3;368(1):34-44.
-
Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4
索夫布韦联合利巴韦林或西美瑞韦治疗基因4型丙肝患者的效果：真实世界研究
Adel Abdel-Moneim et al.
Annals of gastroenterology. 2019 Jan-Feb;32(1):93-98.
-
Sofosbuvir-ribavirin duo for chronic hepatitis C
用于慢性丙型肝炎的索非布韦联合利巴韦林疗法
Basile Njei
Connecticut medicine. 2014 Jun-Jul;78(6):355-6.
-
Sofosbuvir and ribavirin in acute hepatitis C-infected patient with decompensated cirrhosis
索夫布韦联合利巴韦林治疗急性丙型肝炎致失代偿期肝硬化的有效性及安全性：一项开放标签的研究
Hui Liu
Medicine. 2016 Dec;95(49):e5555.
-
Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective
选择性地为等待肝脏移植的丙肝患者使用索非布韦和利巴韦林治疗
Jennifer C Price
Liver international : official journal of the International Association for the Study of the Liver. 2015 Jan;35(1):7-8.
-
Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
Ledipasvir-索非布韦与索非布韦联合利巴韦林治疗慢性HCV感染和出血性疾病患者的效果
C E Walsh et al.
Haemophilia : the official journal of the World Federation of Hemophilia. 2017 Mar;23(2):198-206.
引文链接
复制
已复制！
推荐内容
Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment